ID   PTPA_HUMAN              Reviewed;         358 AA.
AC   Q15257; A2A347; A9IZU4; B4DXM4; Q15258; Q53GZ3; Q5TZQ2; Q9BUK1;
AC   Q9NNZ7; Q9NNZ8; Q9NNZ9;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   22-JUL-2015, entry version 137.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A activator;
DE            EC=5.2.1.8;
DE   AltName: Full=PP2A, subunit B', PR53 isoform;
DE   AltName: Full=Phosphotyrosyl phosphatase activator;
DE            Short=PTPA;
DE   AltName: Full=Serine/threonine-protein phosphatase 2A regulatory subunit 4;
DE   AltName: Full=Serine/threonine-protein phosphatase 2A regulatory subunit B';
GN   Name=PPP2R4; Synonyms=PTPA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Heart;
RX   PubMed=8195217;
RA   Cayla X., Van Hoof C., Bosch M., Waelkens E., Peeters B.,
RA   Merlevede W., Goris J.;
RT   "Molecular cloning, expression, and characterization of PTPA, a
RT   protein that activates the tyrosyl phosphatase activity of protein
RT   phosphatase 2A.";
RL   J. Biol. Chem. 269:15668-15675(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=8530035; DOI=10.1006/geno.1995.1140;
RA   Van Hoof C., Aly M., Garcia A., Cayla X., Cassiman J.-J.,
RA   Merlevede W., Goris J.;
RT   "Structure and chromosomal localization of the human gene of the
RT   phosphotyrosyl phosphatase activator (PTPA) of protein phosphatase
RT   2A.";
RL   Genomics 28:261-272(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3 AND 4).
RX   PubMed=10880964; DOI=10.1046/j.1432-1327.2000.01486.x;
RA   Janssens V., van Hoof C., Martens E., de Baere I., Merlevede W.,
RA   Goris J.;
RT   "Identification and characterization of alternative splice products
RT   encoded by the human phosphotyrosyl phosphatase activator gene.";
RL   Eur. J. Biochem. 267:4406-4413(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-357.
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION IN APOPTOSIS, AND SUBCELLULAR LOCATION.
RX   PubMed=17333320; DOI=10.1007/s10495-006-0050-8;
RA   Azam S., Drobetsky E., Ramotar D.;
RT   "Overexpression of the cis/trans isomerase PTPA triggers caspase 3-
RT   dependent apoptosis.";
RL   Apoptosis 12:1243-1255(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 22-358.
RX   PubMed=16782712; DOI=10.1074/jbc.C600100200;
RA   Magnusdottir A., Stenmark P., Flodin S., Nyman T., Hammarstroem M.,
RA   Ehn M., Bakali H M.A., Berglund H., Nordlund P.;
RT   "The crystal structure of a human PP2A phosphatase activator reveals a
RT   novel fold and highly conserved cleft implicated in protein-protein
RT   interactions.";
RL   J. Biol. Chem. 281:22434-22438(2006).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 20-357.
RX   PubMed=16885030; DOI=10.1016/j.molcel.2006.07.008;
RA   Leulliot N., Vicentini G., Jordens J., Quevillon-Cheruel S.,
RA   Schiltz M., Barford D., van Tilbeurgh H., Goris J.;
RT   "Crystal structure of the PP2A phosphatase activator: implications for
RT   its PP2A-specific PPIase activity.";
RL   Mol. Cell 23:413-424(2006).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), FUNCTION IN MODULATION OF PP2A
RP   SUBSTRATE SPECIFICITY, ATP-BINDING, MUTAGENESIS OF ASP-185; ALA-239;
RP   GLY-240; VAL-244; GLU-305; GLY-325; MET-329 AND LYS-337, AND
RP   INTERACTION WITH THE PP2A(D) COMPLEX.
RX   PubMed=16916641; DOI=10.1016/j.molcel.2006.07.027;
RA   Chao Y., Xing Y., Chen Y., Xu Y., Lin Z., Li Z., Jeffrey P.D.,
RA   Stock J.B., Shi Y.;
RT   "Structure and mechanism of the phosphotyrosyl phosphatase
RT   activator.";
RL   Mol. Cell 23:535-546(2006).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. Acts as a regulatory subunit for serine/threonine-
CC       protein phosphatase 2A (PP2A) modulating its activity or substrate
CC       specificity, probably by inducing a conformational change in the
CC       catalytic subunit, a proposed direct target of the PPIase. Can
CC       reactivate inactive phosphatase PP2A-phosphatase methylesterase
CC       complexes (PP2A(i)) in presence of ATP and Mg(2+) (By similarity).
CC       Reversibly stimulates the variable phosphotyrosyl phosphatase
CC       activity of PP2A core heterodimer PP2A(D) in presence of ATP and
CC       Mg(2+) (in vitro). The phosphotyrosyl phosphatase activity is
CC       dependent of an ATPase activity of the PP2A(D):PPP2R4 complex. Is
CC       involved in apoptosis; the function appears to be independent from
CC       PP2A. {ECO:0000250, ECO:0000269|PubMed:16916641,
CC       ECO:0000269|PubMed:17333320}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBUNIT: Associates with PP2A heterodimeric core enzyme PP2A(D),
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A). Interacts with
CC       PPP2CB (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q4VCS5-2:AMOT; NbExp=3; IntAct=EBI-1774121, EBI-3891843;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17333320}.
CC       Nucleus {ECO:0000269|PubMed:17333320}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q15257-1; Sequence=Displayed;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q15257-2; Sequence=VSP_005123;
CC       Name=3; Synonyms=Delta;
CC         IsoId=Q15257-3; Sequence=VSP_005122;
CC       Name=4; Synonyms=Epsilon;
CC         IsoId=Q15257-4; Sequence=VSP_005124;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SIMILARITY: Belongs to the PTPA-type PPIase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PPP2R4ID41817ch9q34.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73478; CAA51873.1; -; mRNA.
DR   EMBL; X86428; CAA60163.1; -; Genomic_DNA.
DR   EMBL; X86429; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAA60163.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77601.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86431; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77601.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77602.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86432; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77602.1; JOINED; Genomic_DNA.
DR   EMBL; X86428; CAB77603.1; -; Genomic_DNA.
DR   EMBL; X86429; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86430; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86434; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86435; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86436; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86437; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86438; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; X86439; CAB77603.1; JOINED; Genomic_DNA.
DR   EMBL; AK302043; BAG63436.1; -; mRNA.
DR   EMBL; BT020119; AAV38922.1; -; mRNA.
DR   EMBL; AK222788; BAD96508.1; -; mRNA.
DR   EMBL; AL158151; CAM14695.1; -; Genomic_DNA.
DR   EMBL; AL158151; CAP58847.2; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87876.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87882.1; -; Genomic_DNA.
DR   EMBL; BC002545; AAH02545.1; -; mRNA.
DR   EMBL; BC011605; AAH11605.1; -; mRNA.
DR   CCDS; CCDS65156.1; -. [Q15257-3]
DR   CCDS; CCDS6920.1; -. [Q15257-2]
DR   PIR; A54021; A54021.
DR   RefSeq; NP_001180326.1; NM_001193397.1.
DR   RefSeq; NP_001258761.1; NM_001271832.1. [Q15257-3]
DR   RefSeq; NP_066954.2; NM_021131.4. [Q15257-2]
DR   RefSeq; NP_821067.1; NM_178000.2. [Q15257-2]
DR   RefSeq; NP_821068.1; NM_178001.2. [Q15257-1]
DR   RefSeq; NP_821070.1; NM_178003.2. [Q15257-4]
DR   UniGene; Hs.400740; -.
DR   PDB; 2G62; X-ray; 1.60 A; A=22-358.
DR   PDB; 2HV6; X-ray; 1.90 A; A/B=1-358.
DR   PDB; 2HV7; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-358.
DR   PDB; 2IXM; X-ray; 1.50 A; A=20-357.
DR   PDB; 4LAC; X-ray; 2.82 A; B=19-358.
DR   PDB; 4NY3; X-ray; 1.80 A; A/B=22-358.
DR   PDBsum; 2G62; -.
DR   PDBsum; 2HV6; -.
DR   PDBsum; 2HV7; -.
DR   PDBsum; 2IXM; -.
DR   PDBsum; 4LAC; -.
DR   PDBsum; 4NY3; -.
DR   ProteinModelPortal; Q15257; -.
DR   SMR; Q15257; 23-357.
DR   BioGrid; 111516; 58.
DR   IntAct; Q15257; 11.
DR   MINT; MINT-3031079; -.
DR   BindingDB; Q15257; -.
DR   ChEMBL; CHEMBL2505; -.
DR   PhosphoSite; Q15257; -.
DR   BioMuta; PPP2R4; -.
DR   DMDM; 116242737; -.
DR   OGP; Q15257; -.
DR   MaxQB; Q15257; -.
DR   PaxDb; Q15257; -.
DR   PRIDE; Q15257; -.
DR   DNASU; 5524; -.
DR   Ensembl; ENST00000337738; ENSP00000337448; ENSG00000119383.
DR   Ensembl; ENST00000355007; ENSP00000347109; ENSG00000119383. [Q15257-4]
DR   Ensembl; ENST00000357197; ENSP00000349726; ENSG00000119383. [Q15257-3]
DR   Ensembl; ENST00000358994; ENSP00000351885; ENSG00000119383. [Q15257-2]
DR   Ensembl; ENST00000393370; ENSP00000377036; ENSG00000119383. [Q15257-2]
DR   GeneID; 5524; -.
DR   KEGG; hsa:5524; -.
DR   UCSC; uc004bxl.2; human. [Q15257-2]
DR   UCSC; uc004bxm.2; human. [Q15257-1]
DR   UCSC; uc004bxo.2; human. [Q15257-4]
DR   UCSC; uc011mbp.2; human. [Q15257-3]
DR   CTD; 5524; -.
DR   GeneCards; GC09P131873; -.
DR   HGNC; HGNC:9308; PPP2R4.
DR   HPA; CAB022068; -.
DR   HPA; CAB035999; -.
DR   HPA; HPA005695; -.
DR   MIM; 600756; gene.
DR   neXtProt; NX_Q15257; -.
DR   PharmGKB; PA33671; -.
DR   eggNOG; COG5057; -.
DR   GeneTree; ENSGT00390000011500; -.
DR   HOVERGEN; HBG019168; -.
DR   InParanoid; Q15257; -.
DR   KO; K17605; -.
DR   OMA; HPNLEPR; -.
DR   OrthoDB; EOG7KQ21W; -.
DR   PhylomeDB; Q15257; -.
DR   TreeFam; TF105555; -.
DR   ChiTaRS; PPP2R4; human.
DR   EvolutionaryTrace; Q15257; -.
DR   GeneWiki; PPP2R4; -.
DR   GenomeRNAi; 5524; -.
DR   NextBio; 21382; -.
DR   PRO; PR:Q15257; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; Q15257; -.
DR   CleanEx; HS_PPP2R4; -.
DR   ExpressionAtlas; Q15257; baseline and differential.
DR   Genevisible; Q15257; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; TAS:HGNC.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC.
DR   GO; GO:0008601; F:protein phosphatase type 2A regulator activity; IDA:HGNC.
DR   GO; GO:0008160; F:protein tyrosine phosphatase activator activity; IDA:HGNC.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0008152; P:metabolic process; IDA:GOC.
DR   GO; GO:0030472; P:mitotic spindle organization in nucleus; IBA:GO_Central.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:HGNC.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:HGNC.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:HGNC.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IDA:HGNC.
DR   GO; GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC.
DR   GO; GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:HGNC.
DR   GO; GO:0034047; P:regulation of protein phosphatase type 2A activity; IDA:GOC.
DR   InterPro; IPR004327; Phstyr_phstse_ac.
DR   PANTHER; PTHR10012; PTHR10012; 1.
DR   Pfam; PF03095; PTPA; 1.
DR   PIRSF; PIRSF016325; Phstyr_phstse_ac; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Isomerase;
KW   Nucleotide-binding; Nucleus; Polymorphism; Reference proteome;
KW   Rotamase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330}.
FT   CHAIN         2    358       Serine/threonine-protein phosphatase 2A
FT                                activator.
FT                                /FTId=PRO_0000071524.
FT   NP_BIND     183    189       ATP.
FT   NP_BIND     240    242       ATP.
FT   NP_BIND     342    343       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330}.
FT   VAR_SEQ      45    108       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_005122.
FT   VAR_SEQ      73    149       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_005124.
FT   VAR_SEQ      73    107       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8195217,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_005123.
FT   VARIANT      28     28       K -> R (in dbSNP:rs17481693).
FT                                /FTId=VAR_028101.
FT   VARIANT     208    208       R -> Q (in dbSNP:rs4836639).
FT                                /FTId=VAR_028102.
FT   VARIANT     357    357       S -> L (in dbSNP:rs2480452).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_028103.
FT   MUTAGEN     185    185       D->A: Impairs ATPase activity of the
FT                                PP2A(D):PPP2R4 complex; no effect on
FT                                interaction with the PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     239    239       A->D: Impairs ATPase activity of the
FT                                PP2A(D):PPP2R4 complex; no effect on
FT                                interaction with the PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     240    240       G->D: Impairs ATPase activity of the
FT                                PP2A(D):PPP2R4 complex; no effect on
FT                                interaction with the PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     244    244       V->D: Impairs interaction with the
FT                                PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     305    305       E->A: Abolishes interaction with the
FT                                PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     316    316       V->D: Impairs interaction with the
FT                                PP2A(D) complex.
FT   MUTAGEN     325    325       G->D: Abolishes interaction with the
FT                                PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     329    329       M->D: Abolishes interaction with the
FT                                PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   MUTAGEN     337    337       K->G: Impairs interaction with the
FT                                PP2A(D) complex.
FT                                {ECO:0000269|PubMed:16916641}.
FT   CONFLICT    113    113       V -> L (in Ref. 1; CAA51873, 2; CAA60163
FT                                and 3; CAB77601/CAB77602). {ECO:0000305}.
FT   CONFLICT    297    297       Missing (in Ref. 2; CAA60163 and 3;
FT                                CAB77601/CAB77602/CAB77603).
FT                                {ECO:0000305}.
FT   CONFLICT    357    357       S -> V (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        34     40       {ECO:0000244|PDB:2IXM}.
FT   HELIX        43     58       {ECO:0000244|PDB:2IXM}.
FT   TURN         59     61       {ECO:0000244|PDB:2IXM}.
FT   HELIX       107    124       {ECO:0000244|PDB:2IXM}.
FT   STRAND      134    136       {ECO:0000244|PDB:2IXM}.
FT   HELIX       139    156       {ECO:0000244|PDB:2IXM}.
FT   HELIX       161    166       {ECO:0000244|PDB:2IXM}.
FT   HELIX       167    175       {ECO:0000244|PDB:2IXM}.
FT   TURN        181    184       {ECO:0000244|PDB:2IXM}.
FT   HELIX       188    203       {ECO:0000244|PDB:2IXM}.
FT   HELIX       209    211       {ECO:0000244|PDB:2IXM}.
FT   HELIX       212    217       {ECO:0000244|PDB:2IXM}.
FT   HELIX       219    233       {ECO:0000244|PDB:2IXM}.
FT   STRAND      237    240       {ECO:0000244|PDB:2IXM}.
FT   HELIX       243    245       {ECO:0000244|PDB:2IXM}.
FT   STRAND      247    250       {ECO:0000244|PDB:2IXM}.
FT   HELIX       253    261       {ECO:0000244|PDB:2IXM}.
FT   TURN        262    264       {ECO:0000244|PDB:2IXM}.
FT   HELIX       270    274       {ECO:0000244|PDB:2IXM}.
FT   HELIX       276    282       {ECO:0000244|PDB:2IXM}.
FT   HELIX       283    285       {ECO:0000244|PDB:2IXM}.
FT   HELIX       287    298       {ECO:0000244|PDB:2IXM}.
FT   HELIX       303    306       {ECO:0000244|PDB:2IXM}.
FT   HELIX       308    313       {ECO:0000244|PDB:2IXM}.
FT   HELIX       319    333       {ECO:0000244|PDB:2IXM}.
FT   TURN        334    336       {ECO:0000244|PDB:2IXM}.
FT   HELIX       338    341       {ECO:0000244|PDB:2IXM}.
FT   STRAND      348    350       {ECO:0000244|PDB:2IXM}.
FT   STRAND      352    354       {ECO:0000244|PDB:2IXM}.
SQ   SEQUENCE   358 AA;  40668 MW;  2A962521AF5B4CF7 CRC64;
     MAEGERQPPP DSSEEAPPAT QNFIIPKKEI HTVPDMGKWK RSQAYADYIG FILTLNEGVK
     GKKLTFEYRV SEMWNEVHEE KEQAAKQSVS CDECIPLPRA GHCAPSEAIE KLVALLNTLD
     RWIDETPPVD QPSRFGNKAY RTWYAKLDEE AENLVATVVP THLAAAVPEV AVYLKESVGN
     STRIDYGTGH EAAFAAFLCC LCKIGVLRVD DQIAIVFKVF NRYLEVMRKL QKTYRMEPAG
     SQGVWGLDDF QFLPFIWGSS QLIDHPYLEP RHFVDEKAVN ENHKDYMFLE CILFITEMKT
     GPFAEHSNQL WNISAVPSWS KVNQGLIRMY KAECLEKFPV IQHFKFGSLL PIHPVTSG
//
